LSL Pharma Group Inc.
LSL.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,669.45% | 0.10% | 69.44% | -42.52% | -- |
| Total Receivables | -- | -- | 37.20% | 5.15% | -5.15% |
| Inventory | -- | -- | 52.17% | 7.34% | 22.98% |
| Prepaid Expenses | -- | -- | 37.29% | -30.99% | -11.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -- | 46.27% | 1.24% | 10.91% |
|
|
|||||
| Total Current Assets | -- | -- | 46.27% | 1.24% | 10.91% |
| Net Property, Plant & Equipment | -- | -- | 13.79% | 6.66% | 17.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 36.37% | 2.00% | 0.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 8,193.24% | 1.37% | -5.81% |
| Total Assets | -- | -- | 32.37% | 4.07% | 10.88% |
|
|
|||||
| Total Accounts Payable | -- | -- | 20.42% | -5.50% | -12.35% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 367.41% | -23.30% | -45.52% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -59.85% | -7.52% | 4.69% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -- | -- | 7.08% | -7.86% | -8.64% |
|
|
|||||
| Total Current Liabilities | -- | -- | 7.08% | -7.86% | -8.64% |
| Long-Term Debt | -- | -- | 83.65% | 14.38% | -1.98% |
| Short-term Debt | -- | -- | 367.41% | -23.30% | -45.52% |
| Capital Leases | -- | -- | 61.64% | 10.41% | -2.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 4,990.16% | -20.52% | -- |
| Total Liabilities | -- | -- | 52.78% | 1.92% | -5.52% |
|
|
|||||
| Common Stock & APIC | -- | -- | -6.05% | 4.73% | 14.99% |
| Retained Earnings | -- | -- | 27.86% | -3.37% | -1.70% |
| Treasury Stock & Other | -- | -- | -6.12% | 1.31% | -1.05% |
| Total Common Equity | 3.30% | 0.10% | 14.74% | 5.99% | 31.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.30% | 0.10% | 14.74% | 5.99% | 31.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.30% | 0.10% | 14.74% | 5.99% | 31.36% |
|
|
|||||